Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 104
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06523673 - No phaseNot yet taking people in KínaCryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer
- Where
- Nanchang, Shanghai, Ürümqi, Wenzhou, Wuhan
- Életkor
- 18 év and over
- People
- 134
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06580665 - 2. fázisTaking peopleCranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 54
- Run by
- Fudan University
See details and how to joinNCT06501391 - 4. fázisTaking peopleBefotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 592
- Run by
- Fudan University
See details and how to joinNCT06561620 - 2. fázisTaking peopleIntra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
- Where
- Guangzhou
- Életkor
- 18 év to 99 év
- People
- 100
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT04770207 - 2. fázisTaking peopleAdebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT06562920 - No phaseTaking peopleBAI-BACE for Advanced Lung Squamous Cell Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 85
- Run by
- Sun Yat-sen University
See details and how to joinNCT06377735 - 2. fázisNot yet taking people in KínaA Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 213
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06524518 - 3. fázisTaking peopleEfficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 12 000
- Run by
- Hunan Province Tumor Hospital
See details and how to joinNCT05055908 - No phaseTaking peopleSurgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Ruijin Hospital
See details and how to joinNCT06534489 - 2. fázisTaking peopleMilaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
- Where
- Hangzhou
- Életkor
- 18 év to 65 év
- People
- 260
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06534762 - 2. fázisTaking peopleAdjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma
- Where
- Shanghai
- Életkor
- 18 év to 74 év
- People
- 62
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06528847 - 2. fázisTaking peopleBefotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 23
- Run by
- Sun Yat-sen University
See details and how to joinNCT06517953 - No phaseTaking peopleChemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer
- Where
- Qingdao
- Életkor
- 18 év to 80 év
- People
- 70
- Run by
- Qingdao Central Hospital
See details and how to joinNCT06514118 - 2. fázisTaking peopleSerplulimab Combined With CCRT for LS-SCLC.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 96
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06295926 - No phaseTaking peopleThe Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 118
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT06244264 - 2. fázisTaking peopleNeoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
- Where
- Guanzhou
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06492421 - 1/2. fázisTaking peopleA Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
- Where
- Changsha, Hefei, Linhai, Nanjing, Shanghai, Zhengzhou
- Életkor
- 18 év and over
- People
- 94
- Run by
- Suzhou Genhouse Bio Co., Ltd.
See details and how to joinNCT06306456 - 2. fázisTaking peopleCheckpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06483347 - 2. fázisTaking peopleNeoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 104
- Run by
- Tang-Du Hospital
See details and how to joinNCT06485544 - No phaseTaking peopleRisk Factors for Postoperative Cough in Patients Undergoing Thoracoscopic Lung Resection
- Where
- Kunming
- Életkor
- 18 év to 70 év
- People
- 1000
- Run by
- Hematology department of the 920th hospital
See details and how to joinNCT06476249 - 2/3. fázisTaking peopleInterventional Software for Multi-immunotherapy of Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06478108 - 1. fázisTaking peopleIntratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT04952272 - 1. fázisTaking peopleGPC3/Mesothelin-CAR-γδT Cells Against Cancers
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06196294 - 2. fázisTaking peopleAdebrelimab + Apatinib in SCLC Maintenance Therapy
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Tang-Du Hospital
See details and how to joinNCT06475209